Chronic Conditions

Chronic Conditions

Teladoc-Livongo: The $18.5 Billion Valuation Trap & AI Lessons

The healthcare AI landscape is rife with innovation, promising transformative shifts in patient care and operational…

Editorial Team Jul 17, 2026 · 5 min read

Chronic Conditions

Teladoc-Livongo: The $13.7 Billion Impairment & Clinical Validation Gap

The acquisition of Livongo by Teladoc in 2020 for an eye-watering $18.5 billion was heralded as…

Editorial Team Jul 16, 2026 · 9 min read

Chronic Conditions

Teladoc’s Billion Dollar Blunder: The Clinical Validation Gap

The $18.5 billion merger of Teladoc and Livongo in 2020 was heralded as a transformative moment…

Editorial Team Jul 13, 2026 · 6 min read